Literature DB >> 32910521

Small ubiquitin-like modifier 2 (SUMO2) is critical for memory processes in mice.

Shu Yu1,2, Francesca Galeffi3,4,5,6, Ramona M Rodriguiz7, Zhuoran Wang1, Yuntian Shen1,2, Jingjun Lyu1, Ran Li1, Joshua D Bernstock8, Kory R Johnson9, Shuai Liu1, Huaxin Sheng1, Dennis A Turner3,4,5,6, William C Wetsel5,7,10, Wulf Paschen1, Wei Yang1.   

Abstract

Small ubiquitin-like modifier (SUMO1-3) conjugation (SUMOylation), a posttranslational modification, modulates almost all major cellular processes. Mounting evidence indicates that SUMOylation plays a crucial role in maintaining and regulating neural function, and importantly its dysfunction is implicated in cognitive impairment in humans. We have previously shown that simultaneously silencing SUMO1-3 expression in neurons negatively affects cognitive function. However, the roles of the individual SUMOs in modulating cognition and the mechanisms that link SUMOylation to cognitive processes remain unknown. To address these questions, in this study, we have focused on SUMO2 and generated a new conditional Sumo2 knockout mouse line. We found that conditional deletion of Sumo2 predominantly in forebrain neurons resulted in marked impairments in various cognitive tests, including episodic and fear memory. Our data further suggest that these abnormalities are attributable neither to constitutive changes in gene expression nor to alterations in neuronal morphology, but they involve impairment in dynamic SUMOylation processes associated with synaptic plasticity. Finally, we provide evidence that dysfunction on hippocampal-based cognitive tasks was associated with a significant deficit in the maintenance of hippocampal long-term potentiation in Sumo2 knockout mice. Collectively, these data demonstrate that protein conjugation by SUMO2 is critically involved in cognitive processes.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  LTP; knockout; memory impairment; posttranslational modification

Year:  2020        PMID: 32910521      PMCID: PMC7606628          DOI: 10.1096/fj.202000850RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  46 in total

1.  Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.

Authors:  Wei Yang; Huaxin Sheng; J Will Thompson; Shengli Zhao; Liangli Wang; Pei Miao; Xiaozhi Liu; M Arthur Moseley; Wulf Paschen
Journal:  Stroke       Date:  2014-02-25       Impact factor: 7.914

Review 2.  A Brief History of Long-Term Potentiation.

Authors:  Roger A Nicoll
Journal:  Neuron       Date:  2017-01-18       Impact factor: 17.173

Review 3.  The molecular and systems biology of memory.

Authors:  Eric R Kandel; Yadin Dudai; Mark R Mayford
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

4.  SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.

Authors:  Liangli Wang; Carolien Wansleeben; Shengli Zhao; Pei Miao; Wulf Paschen; Wei Yang
Journal:  EMBO Rep       Date:  2014-06-02       Impact factor: 8.807

5.  SUMO modification of Huntingtin and Huntington's disease pathology.

Authors:  Joan S Steffan; Namita Agrawal; Judit Pallos; Erica Rockabrand; Lloyd C Trotman; Natalia Slepko; Katalin Illes; Tamas Lukacsovich; Ya-Zhen Zhu; Elena Cattaneo; Pier Paolo Pandolfi; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

6.  O-linked β-N-acetylglucosamine modification of proteins is activated in post-ischemic brains of young but not aged mice: Implications for impaired functional recovery from ischemic stress.

Authors:  Shuai Liu; Huaxin Sheng; Zhui Yu; Wulf Paschen; Wei Yang
Journal:  J Cereb Blood Flow Metab       Date:  2015-09-30       Impact factor: 6.200

7.  SUMOylation controls the neurodevelopmental function of the transcription factor Zbtb20.

Authors:  Silvia Ripamonti; Orr Shomroni; Jeong Seop Rhee; Kamal Chowdhury; Olaf Jahn; Klaus Peter Hellmann; Stefan Bonn; Nils Brose; Marilyn Tirard
Journal:  J Neurochem       Date:  2020-04-16       Impact factor: 5.372

8.  SUMO1 Affects Synaptic Function, Spine Density and Memory.

Authors:  Shinsuke Matsuzaki; Linda Lee; Erin Knock; Tharan Srikumar; Mikako Sakurai; Lili-Naz Hazrati; Taiichi Katayama; Agnieszka Staniszewski; Brian Raught; Ottavio Arancio; Paul E Fraser
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

9.  SUMOylation of the MAGUK protein CASK regulates dendritic spinogenesis.

Authors:  Hsu-Wen Chao; Chen-Jei Hong; Tzyy-Nan Huang; Yi-Ling Lin; Yi-Ping Hsueh
Journal:  J Cell Biol       Date:  2008-07-07       Impact factor: 10.539

10.  SUMOylation regulates kainate-receptor-mediated synaptic transmission.

Authors:  Stéphane Martin; Atsushi Nishimune; Jack R Mellor; Jeremy M Henley
Journal:  Nature       Date:  2007-05-07       Impact factor: 49.962

View more
  1 in total

1.  Botanical Drug Puerarin Ameliorates Liposaccharide-Induced Depressive Behaviors in Mice via Inhibiting RagA/mTOR/p70S6K Pathways.

Authors:  Jia Zhao; Yizhen Jia; Wei Zhao; Huixin Chen; Xiuying Zhang; Fung Yin Ngo; Dan Luo; Youqiang Song; Lixing Lao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.